However, we point out that while CD4 count is still the gold standard for evaluating immune function in HIV/AIDS patients, utilizing TLC as a substitute clinical measure in a constrained situation can offer insightful information for disease monitoring and response assessment. This evidence concerns the gene CD4 and AIDS.